Rethinking HLA-B27 Testing: What HLA-B27 Can-and Cannot-Tell Us

Affiliations

• ¹ M. Beaufrère, MD, PhD, F. Costantino, MD, PhD, Rheumatology Department, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, and Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection & Inflammation, Laboratory of Excellence INFIBREX, Montigny-Le-Bretonneux.
• ² B. Cherqaoui, MD, PhD, Pediatrics Department, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, France, and Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection & Inflammation, Laboratory of Excellence INFIBREX, Montigny-Le-Bretonneux, France.
• ³ M. Beaufrère, MD, PhD, F. Costantino, MD, PhD, Rheumatology Department, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, and Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection & Inflammation, Laboratory of Excellence INFIBREX, Montigny-Le-Bretonneux; felicie.costantino@aphp.fr.